Your Complete Mounjaro to Wegovy Switching Guide
Which Is Better Mounjaro or Wegovy: Understanding the Switch & Save Advantage
When evaluating which is better between Mounjaro or Wegovy for your switching needs, the decision often comes down to individual response, cost considerations, and practical factors. Mounjaro contains tirzepatide, a dual GIP and GLP-1 receptor agonist, while Wegovy contains semaglutide, a GLP-1 receptor agonist only. This fundamental difference in mechanism may influence how your body responds to each medication. Many patients consider switching when their current medication becomes costly, causes persistent side effects, or when seeking different clinical outcomes under medical supervision.
The Switch & Save approach at EverydayMeds recognises that medication transitions should be both clinically appropriate and financially sensible. Our pharmacy stocks both Mounjaro and Wegovy, eliminating the need to establish relationships with multiple suppliers when making your switch. Your prescriber can provide specific guidance on timing your transition, managing any overlap period, and monitoring your response to ensure continuity of care. This seamless approach reduces the complexity often associated with changing weight management medications.
Mounjaro vs Wegovy Pricing Comparison: Switch & Save Benefits
Understanding the cost implications helps answer which is better between Mounjaro or Wegovy from a financial perspective. Wegovy pricing at EverydayMeds starts at £79.99 for the 0.25mg starter dose, progressing through £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), to £209.99 for the maintenance 2.4mg dose. New customers can apply discount code FIRST40 at checkout, while returning customers use code DOSE25 to achieve these competitive prices. Our bundle options provide convenient multi-month supplies, such as the Intro Trio (0.25mg, 0.5mg, 1mg) for £299.99 or the Progress Duo (0.5mg, 1mg) for £189.99.
When switching from Mounjaro to Wegovy, patients often discover potential cost savings depending on their dosing requirements and insurance coverage. The transparent pricing structure allows you to plan your medication budget effectively, whether you're transitioning due to supply issues, cost concerns, or clinical preference. Both medications require similar dose escalation protocols, so understanding the full cost trajectory helps make informed switching decisions. EverydayMeds' competitive pricing, combined with discount codes, often makes Wegovy an attractive switching option for cost-conscious patients.
Clinical Evidence: Which Is Better Mounjaro or Wegovy Based on Research
The clinical evidence for both medications demonstrates significant efficacy in weight management, though direct head-to-head comparisons remain limited. Wegovy's STEP trial programme showed that patients taking semaglutide alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks in STEP 1, compared to 2.4% with placebo (Wilding et al., NEJM, 2021). The SELECT trial further demonstrated a 20% reduction in major cardiovascular events, adding another dimension to Wegovy's clinical profile.
Mounjaro's clinical data from the SURMOUNT trials indicated that tirzepatide may produce greater weight loss in some patient populations, though comparing trial results directly can be misleading due to different study designs and patient characteristics. When determining which is better between Mounjaro or Wegovy for your specific situation, your prescriber will consider your medical history, current response, side effect profile, and treatment goals rather than relying solely on population-level trial data.
How Wegovy Works: Mechanism When Switching from Mounjaro
Wegovy functions as a GLP-1 receptor agonist, mimicking the natural incretin hormone that regulates blood sugar and appetite. After injection, semaglutide binds to GLP-1 receptors in the brain's appetite control centres, promoting feelings of fullness and reducing food cravings. This mechanism slows gastric emptying, meaning food stays in your stomach longer, contributing to sustained satiety between meals. Unlike Mounjaro's dual GIP/GLP-1 action, Wegovy works exclusively through the GLP-1 pathway, which may result in different side effect profiles or efficacy patterns. Understanding this mechanistic difference helps explain why some patients may respond better to one medication over another when making a supervised switch.
Switching Process: From Assessment to Wegovy Delivery
The switching process begins with our 3-minute online clinical assessment, where you'll detail your current medication, dosing history, and reasons for considering a change. Our prescribers review your information within 3 working days (or 24 hours with express service), considering appropriate dose conversion and timing for your transition. Most switches involve a washout period or careful overlap, depending on your current medication and prescriber recommendations. Once approved, your Wegovy is dispatched via next-day delivery using temperature-controlled cold-chain logistics to maintain medication integrity. This streamlined process ensures minimal disruption to your weight management programme while maintaining clinical safety throughout the transition.
Storage Advantages: Wegovy vs Mounjaro Practical Considerations
When comparing which is better between Mounjaro or Wegovy for practical use, storage requirements present a notable difference. Wegovy can remain at room temperature (below 30°C) for up to 6 weeks once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit. This extended stability makes Wegovy more convenient for travel, work situations, or households where refrigerator space is limited. The FlexTouch pen design provides consistent dosing accuracy, while the weekly injection schedule (same day each week) helps maintain routine consistency. Proper storage ensures medication potency throughout your switching period, particularly important when transitioning between different GLP-1 medications where maintaining therapeutic levels supports treatment continuity.
Which Is Better Mounjaro or Wegovy: Personalised Switching Strategies
Determining which is better between Mounjaro or Wegovy requires individualised assessment beyond generic comparisons. Patients commonly switch due to side effect management—some find Wegovy's GLP-1-only mechanism causes fewer gastrointestinal issues, while others prefer Mounjaro's dual-pathway approach. Cost considerations often drive switching decisions, particularly when insurance coverage changes or when seeking more predictable monthly expenses. Supply chain stability represents another factor, as having reliable access to your chosen medication prevents treatment interruptions.
Your switching strategy should account for your response timeline, current dose equivalency, and treatment goals. Some patients switch during their dose escalation phase, while others transition after reaching maintenance dosing. EverydayMeds supports both approaches with flexible ordering options and clinical guidance to ensure your switch maintains therapeutic momentum. The decision ultimately depends on your individual circumstances, prescriber recommendations, and personal treatment priorities rather than broad population comparisons.
Complete Your Switch: Expert Support and Competitive Pricing
Ready to explore which is better between Mounjaro or Wegovy for your specific needs? EverydayMeds provides comprehensive switching support through our GPhC-registered pharmacy (#9012878), ensuring clinical safety and regulatory compliance throughout your transition. Our prescribers offer personalised dose conversion guidance, while our competitive pricing with discount codes FIRST40 (new customers) or DOSE25 (returning customers) makes switching financially attractive. The combination of clinical expertise, medication availability, and cost-effective pricing creates an ideal environment for successful medication transitions. Visit https://everydaymeds.co.uk/collections/weight-loss to begin your switching assessment, or contact our clinical team for personalised guidance on timing and dosing strategies. Both medications are prescription-only medicines requiring clinical assessment and should be used alongside a reduced-calorie diet and increased physical activity for optimal results.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
